Compare BLDR & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLDR | CRL |
|---|---|---|
| Founded | 1998 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3B | 8.6B |
| IPO Year | 2005 | 1999 |
| Metric | BLDR | CRL |
|---|---|---|
| Price | $70.96 | $155.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 12 |
| Target Price | $121.76 | ★ $198.27 |
| AVG Volume (30 Days) | ★ 2.6M | 769.9K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,190,638,000.00 | $1,857,601,000.00 |
| Revenue This Year | $0.71 | N/A |
| Revenue Next Year | $4.52 | $3.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.48 |
| 52 Week Low | $66.14 | $132.58 |
| 52 Week High | $151.03 | $228.88 |
| Indicator | BLDR | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 38.37 | 39.85 |
| Support Level | N/A | $147.22 |
| Resistance Level | $130.47 | $184.75 |
| Average True Range (ATR) | 3.38 | 8.76 |
| MACD | -0.65 | -2.44 |
| Stochastic Oscillator | 31.49 | 20.29 |
Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.